Importer of Controlled Substances Application: Clinical Supplies Management Holdings, Inc., 39127-39128 [2018-16939]

Download as PDF Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices sradovich on DSK3GMQ082PROD with NOTICES appropriate Indian Tribes or Native Hawaiian organizations, and has determined that there is no cultural affiliation between the human remains and any present-day Indian Tribes or Native Hawaiian organizations. Representatives of any Indian Tribe or Native Hawaiian organization not identified in this notice that wish to request transfer of control of these human remains should submit a written request to the NYU College of Dentistry. If no additional requestors come forward, transfer of control of the human remains to the Indian Tribes or Native Hawaiian organizations stated in this notice may proceed. DATES: Representatives of any Indian Tribe or Native Hawaiian organization not identified in this notice that wish to request transfer of control of these human remains should submit a written request with information in support of the request to the NYU College of Dentistry at the address in this notice by September 7, 2018. ADDRESSES: Dr. Louis Terracio, NYU College of Dentistry, 345 East 24th Street, New York, NY 10010, telephone (212) 998–9717, email louis.terracio@ nyu.edu. SUPPLEMENTARY INFORMATION: Notice is here given in accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), 25 U.S.C. 3003, of the completion of an inventory of human remains under the control of the NYU College of Dentistry, New York City, NY. The human remains were removed from Shinnecock Hills, Suffolk County, Long Island, NY. This notice is published as part of the National Park Service’s administrative responsibilities under NAGPRA, 25 U.S.C. 3003(d)(3) and 43 CFR 10.11(d). The determinations in this notice are the sole responsibility of the museum, institution, or Federal agency that has control of the Native American human remains. The National Park Service is not responsible for the determinations in this notice. Suffolk County, NY. In 1926, the town of Southampton donated the human remains, which consist of the cranial fragments of one adult, to the Museum of the American Indian, Heye Foundation. They were accessioned into the collection of the Department of Physical Anthropology of the Museum of the American Indian, Heye Foundation that same year. In 1956, the human remains were transferred to Dr. Theodore Kazamiroff, NYU College of Dentistry. No known individuals were identified. No associated funerary objects are present. The age of the human remains cannot be determined from the available information. Forensic examination revealed diagnostic features of an individual with Native American ancestry. Without any information about the site or age of the remains, no identifiable earlier group can be determined. Shinnecock Hills, which lies near the northeastern end of Long Island, is not included in any treaties, Acts of Congress, or Executive Orders that establish aboriginal land. The area is, however, within territory that was long recognized by the tribe, the town of Southampton, and the state of New York as Shinnecock land. In 1703, the Shinnecock and town of Southampton reached an agreement in which the Shinnecock held a 1,000 year lease of approximately 3,500 acres, including Shinnecock Hills. The area was subsequently referred to as the Shinnecock Reservation in various state and local documents. The Shinnecock renegotiated their lease in 1859 and relinquished the lands at Shinnecock Hills in exchange for fee title to the land at Shinnecock Neck. The current Shinnecock Reservation, which no longer includes Shinnecock Hills, was placed into trust after the tribe was federally recognized in 2010. The Department of Interior proposed finding on the Shinnecock petition for federal recognition identifies Shinnecock Hills as part of the pre-1859 Shinnecock Reservation. Consultation A detailed assessment of the human remains was made by the NYU College of Dentistry professional staff in consultation with representatives of the Delaware Nation, Oklahoma; Delaware Tribe of Indians; Shinnecock Indian Nation; and Stockbridge Munsee Community, Wisconsin. Determinations Made by the NYU College of Dentistry Officials of the NYU College of Dentistry have determined that: • Pursuant to 25 U.S.C. 3001(9), the human remains described in this notice are Native American based on diagnostic cranial features observed during forensic examination. • Pursuant to 25 U.S.C. 3001(9), the human remains described in this notice represent the physical remains of one individual of Native American ancestry. • Pursuant to 25 U.S.C. 3001(2), a relationship of shared group identity History and Description of the Remains At an unknown date, human remains representing, at minimum, one individual were removed from an unknown site in Shinnecock Hills, VerDate Sep<11>2014 22:37 Aug 07, 2018 Jkt 244001 PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 39127 cannot be reasonably traced between the Native American human remains and any present-day Indian Tribe. • Authoritative governmental documents, including the Shinnecock Indian Nation’s federal recognition decision, state agreements, and local property records indicate that the land from which the Native American human remains were removed is the aboriginal land of the Shinnecock Indian Nation. • Pursuant to 43 CFR 10.11(c)(1), the disposition of the human remains may be to the Shinnecock Indian Nation. Additional Requestors and Disposition Representatives of any Indian Tribe or Native Hawaiian organization not identified in this notice that wish to request transfer of control of these human remains should submit a written request with information in support of the request to Dr. Louis Terracio, NYU College of Dentistry, 345 East 24th Street, New York, NY 10010, telephone (212) 998–9717, email louis.terracio@ nyu.edu, by September 7, 2018. After that date, if no additional requestors have come forward, transfer of control of the human remains to the Shinnecock Indian Nation may proceed. The NYU College of Dentistry is responsible for notifying the Shinnecock Indian Nation that this notice has been published. Dated: June 29, 2018. Melanie O’Brien, Manager, National NAGPRA Program. [FR Doc. 2018–16920 Filed 8–7–18; 8:45 am] BILLING CODE 4312–52–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Clinical Supplies Management Holdings, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 7, 2018. Such persons may also file a written request for a hearing on the application on or before September 7, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be DATES: E:\FR\FM\08AUN1.SGM 08AUN1 39128 Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on June 29, 2018, Clinical Supplies Management Holdings, Inc., 342 42nd Street South, Fargo, North Dakota 58103–1132 applied to be registered as an importer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance Marihuana ..................... Tetrahydrocannabinols Drug code 7360 7370 Schedule I I The company plans to import the listed controlled substances to manufacture bulk controlled substances for use in clinical trials only. Dated: July 31, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018–16939 Filed 8–7–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: AndersonBrecon Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 7, 2018. Such persons may also file a written request for a hearing on the application on or before September 7, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement DATES: Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007) SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on May 2, 2018, AndersonBrecon Inc., 5775 Logistics Parkway, Rockford, Illinois 61109 applied to be registered as an importer of the following basic class of controlled substance: Drug code Controlled substance sradovich on DSK3GMQ082PROD with NOTICES Tetrahydrocannabinols ......................................................................................................................................... The company plans to import the listed controlled substances for clinical trial only. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or nonapproved finished dosage forms for commercial sale. Dated: July 31, 2018. John J. Martin, Assistant Administrator. BILLING CODE 4410–09–P 22:37 Aug 07, 2018 Jkt 244001 Drug Enforcement Administration [Docket No. DEA–392] PO 00000 Notice of registration. Frm 00088 Fmt 4703 Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances. Sfmt 4703 The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. SUPPLEMENTARY INFORMATION: DEPARTMENT OF JUSTICE Importer of Controlled Substances Registration VerDate Sep<11>2014 I SUMMARY: [FR Doc. 2018–16937 Filed 8–7–18; 8:45 am] ACTION: 7370 Schedule E:\FR\FM\08AUN1.SGM 08AUN1

Agencies

[Federal Register Volume 83, Number 153 (Wednesday, August 8, 2018)]
[Notices]
[Pages 39127-39128]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16939]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Clinical Supplies 
Management Holdings, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before September 7, 2018. 
Such persons may also file a written request for a hearing on the 
application on or before September 7, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be

[[Page 39128]]

sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152. All request for hearing 
should also be sent to: (1) Drug Enforcement Administration, Attn: 
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; 
and (2) Drug Enforcement Administration, Attn: DEA Federal Register 
Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 
22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on June 
29, 2018, Clinical Supplies Management Holdings, Inc., 342 42nd Street 
South, Fargo, North Dakota 58103-1132 applied to be registered as an 
importer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana..............................     7360  I
Tetrahydrocannabinols..................     7370  I
------------------------------------------------------------------------

    The company plans to import the listed controlled substances to 
manufacture bulk controlled substances for use in clinical trials only.

    Dated: July 31, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-16939 Filed 8-7-18; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.